MoneyWorks4Me

Vasundhara Rasayans - Quaterly Results

14 Aug 2024 Evaluate
Net sales declined -8.45%  to  Rs. 76.30 million from Rs. 83.34 millions.The Company's Net profit for the June 2024 quarter have declined marginally to Rs. 8.62  millions as against Rs. 9.55 millions reported during the corresponding quarter ended.Operating Profit reported a sharp decline to 13.04 millions from 13.97 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 76.30 83.34 -8.45 76.30 83.34 -8.45 370.18 379.41 -2.43
Other Income 4.47 4.23 5.67 4.47 4.23 5.67 19.41 22.98 -15.54
PBIDT 13.04 13.97 -6.66 13.04 13.97 -6.66 83.33 78.06 6.75
Interest 0.55 0.64 -14.06 0.55 0.64 -14.06 2.64 1.31 101.53
PBDT 12.49 13.33 -6.30 12.49 13.33 -6.30 80.69 76.75 5.13
Depreciation 0.84 0.42 100.00 0.84 0.42 100.00 1.74 2.00 -13.00
PBT 11.65 12.91 -9.76 11.65 12.91 -9.76 78.95 74.75 5.62
TAX 3.03 3.36 -9.82 3.03 3.36 -9.82 20.36 18.85 8.01
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.48 -0.02 -2500.00
PAT 8.62 9.55 -9.74 8.62 9.55 -9.74 58.59 55.90 4.81
Equity 31.78 31.78 0.00 31.78 31.78 0.00 31.78 31.78 0.00
PBIDTM(%) 17.09 16.76 1.95 17.09 16.76 1.95 22.51 20.57 9.41
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..